US Stock MarketDetailed Quotes

Relmada Therapeutics (RLMD)

Watchlist
  • 6.900
  • -0.520-7.01%
Close May 15 16:00 ET
  • 6.900
  • 0.0000.00%
Post 16:10 ET
723.74MMarket Cap-6.33P/E (TTM)

Relmada Therapeutics (RLMD) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
16.60%-15.07M
11.53%-45.79M
-65.87%-14.6M
59.64%-6.72M
51.73%-6.4M
-38.59%-18.07M
-0.19%-51.76M
14.15%-8.8M
-43.21%-16.66M
0.08%-13.26M
Net income from continuing operations
-8.50%-19.05M
28.25%-57.39M
-6.49%-19.87M
53.55%-10.09M
44.47%-9.87M
19.56%-17.56M
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
Operating gains losses
115.67%9.87K
121.13%79.21K
364.23%107.92K
155.09%81.44K
64.54%-47.2K
-18.48%-62.95K
-109.22%-374.93K
-101.22%-40.84K
-385.87%-147.84K
---133.11K
Other non cash items
----
--905.23K
----
----
----
--905.23K
----
----
----
----
Change In working capital
95.82%-199.33K
-149.40%-3.95M
-57.51%1.23M
82.23%-438.07K
100.95%24.91K
-895.31%-4.77M
-151.41%-1.58M
-46.50%2.9M
-49.18%-2.47M
-1,288.33%-2.62M
-Change in receivables
----
----
----
----
----
----
--0
--0
--0
--0
-Change in prepaid assets
-238.74%-402.43K
-127.77%-88.79K
-101.07%-7.5K
51.45%-493.12K
-40.39%121.78K
-32.97%290.05K
-88.75%319.75K
-57.77%698.34K
-261.89%-1.02M
153.11%204.31K
-Change in payables and accrued expense
104.01%203.1K
-102.84%-3.86M
-43.71%1.24M
103.80%55.05K
96.57%-96.87K
-3,129.32%-5.06M
-594.48%-1.9M
-41.56%2.2M
36.41%-1.45M
-566.78%-2.82M
Cash from discontinued investing activities
Operating cash flow
16.60%-15.07M
11.53%-45.79M
-65.87%-14.6M
59.64%-6.72M
51.73%-6.4M
-38.59%-18.07M
-0.19%-51.76M
14.15%-8.8M
-43.21%-16.66M
0.08%-13.26M
Investing cash flow
Cash flow from continuing investing activities
-980.40%-135.23M
-193.36%-48.14M
-778.07%-76.93M
-58.17%6.75M
-52.34%6.68M
52.70%15.36M
2.20%51.56M
46.56%11.35M
318.19%16.14M
1,316.79%14.01M
Net investment purchase and sale
-980.40%-135.23M
-193.36%-48.14M
-778.07%-76.93M
-58.17%6.75M
-52.34%6.68M
52.70%15.36M
2.20%51.56M
46.56%11.35M
318.19%16.14M
1,316.79%14.01M
Cash from discontinued investing activities
Investing cash flow
-980.40%-135.23M
-193.36%-48.14M
-778.07%-76.93M
-58.17%6.75M
-52.34%6.68M
52.70%15.36M
2.20%51.56M
46.56%11.35M
318.19%16.14M
1,316.79%14.01M
Financing cash flow
Cash flow from continuing financing activities
156.57M
232,034.78%93.56M
54,386.89%93.64M
0
-73.02K
0
59.03%-40.34K
-75.18%-172.49K
-89.6K
0
Net common stock issuance
--160M
--93.64M
38,048.92%93.64M
----
----
--0
--0
---246.75K
--0
----
Proceeds from stock option exercised by employees
----
--0
----
----
--0
--0
--246.75K
----
----
--0
Net other financing activities
---3.43M
74.56%-73.02K
--0
--0
----
----
-191.57%-287.09K
---172.49K
---89.6K
--0
Cash from discontinued financing activities
Financing cash flow
--156.57M
232,034.78%93.56M
54,386.89%93.64M
--0
---73.02K
--0
59.03%-40.34K
-75.18%-172.49K
---89.6K
--0
Net cash flow
Beginning cash position
-9.35%3.5M
-5.73%3.86M
-6.69%1.38M
-35.13%1.35M
-13.88%1.15M
-5.73%3.86M
-24.17%4.09M
-77.85%1.48M
-85.58%2.09M
-95.38%1.34M
Current changes in cash
331.96%6.28M
-53.70%-360.49K
-11.01%2.11M
105.17%31.13K
-72.89%203.65K
1.79%-2.71M
82.02%-234.54K
191.03%2.37M
92.25%-602.47K
105.21%751.24K
End cash Position
750.34%9.78M
-9.35%3.5M
-9.35%3.5M
-6.69%1.38M
-35.13%1.35M
-13.88%1.15M
-5.73%3.86M
-5.73%3.86M
-77.85%1.48M
-85.58%2.09M
Free cash flow
16.60%-15.07M
11.53%-45.79M
-65.87%-14.6M
59.64%-6.72M
51.73%-6.4M
-38.59%-18.07M
-0.19%-51.76M
14.15%-8.8M
-43.21%-16.66M
0.08%-13.26M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 16.60%-15.07M11.53%-45.79M-65.87%-14.6M59.64%-6.72M51.73%-6.4M-38.59%-18.07M-0.19%-51.76M14.15%-8.8M-43.21%-16.66M0.08%-13.26M
Net income from continuing operations -8.50%-19.05M28.25%-57.39M-6.49%-19.87M53.55%-10.09M44.47%-9.87M19.56%-17.56M19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M
Operating gains losses 115.67%9.87K121.13%79.21K364.23%107.92K155.09%81.44K64.54%-47.2K-18.48%-62.95K-109.22%-374.93K-101.22%-40.84K-385.87%-147.84K---133.11K
Other non cash items ------905.23K--------------905.23K----------------
Change In working capital 95.82%-199.33K-149.40%-3.95M-57.51%1.23M82.23%-438.07K100.95%24.91K-895.31%-4.77M-151.41%-1.58M-46.50%2.9M-49.18%-2.47M-1,288.33%-2.62M
-Change in receivables --------------------------0--0--0--0
-Change in prepaid assets -238.74%-402.43K-127.77%-88.79K-101.07%-7.5K51.45%-493.12K-40.39%121.78K-32.97%290.05K-88.75%319.75K-57.77%698.34K-261.89%-1.02M153.11%204.31K
-Change in payables and accrued expense 104.01%203.1K-102.84%-3.86M-43.71%1.24M103.80%55.05K96.57%-96.87K-3,129.32%-5.06M-594.48%-1.9M-41.56%2.2M36.41%-1.45M-566.78%-2.82M
Cash from discontinued investing activities
Operating cash flow 16.60%-15.07M11.53%-45.79M-65.87%-14.6M59.64%-6.72M51.73%-6.4M-38.59%-18.07M-0.19%-51.76M14.15%-8.8M-43.21%-16.66M0.08%-13.26M
Investing cash flow
Cash flow from continuing investing activities -980.40%-135.23M-193.36%-48.14M-778.07%-76.93M-58.17%6.75M-52.34%6.68M52.70%15.36M2.20%51.56M46.56%11.35M318.19%16.14M1,316.79%14.01M
Net investment purchase and sale -980.40%-135.23M-193.36%-48.14M-778.07%-76.93M-58.17%6.75M-52.34%6.68M52.70%15.36M2.20%51.56M46.56%11.35M318.19%16.14M1,316.79%14.01M
Cash from discontinued investing activities
Investing cash flow -980.40%-135.23M-193.36%-48.14M-778.07%-76.93M-58.17%6.75M-52.34%6.68M52.70%15.36M2.20%51.56M46.56%11.35M318.19%16.14M1,316.79%14.01M
Financing cash flow
Cash flow from continuing financing activities 156.57M232,034.78%93.56M54,386.89%93.64M0-73.02K059.03%-40.34K-75.18%-172.49K-89.6K0
Net common stock issuance --160M--93.64M38,048.92%93.64M----------0--0---246.75K--0----
Proceeds from stock option exercised by employees ------0----------0--0--246.75K----------0
Net other financing activities ---3.43M74.56%-73.02K--0--0---------191.57%-287.09K---172.49K---89.6K--0
Cash from discontinued financing activities
Financing cash flow --156.57M232,034.78%93.56M54,386.89%93.64M--0---73.02K--059.03%-40.34K-75.18%-172.49K---89.6K--0
Net cash flow
Beginning cash position -9.35%3.5M-5.73%3.86M-6.69%1.38M-35.13%1.35M-13.88%1.15M-5.73%3.86M-24.17%4.09M-77.85%1.48M-85.58%2.09M-95.38%1.34M
Current changes in cash 331.96%6.28M-53.70%-360.49K-11.01%2.11M105.17%31.13K-72.89%203.65K1.79%-2.71M82.02%-234.54K191.03%2.37M92.25%-602.47K105.21%751.24K
End cash Position 750.34%9.78M-9.35%3.5M-9.35%3.5M-6.69%1.38M-35.13%1.35M-13.88%1.15M-5.73%3.86M-5.73%3.86M-77.85%1.48M-85.58%2.09M
Free cash flow 16.60%-15.07M11.53%-45.79M-65.87%-14.6M59.64%-6.72M51.73%-6.4M-38.59%-18.07M-0.19%-51.76M14.15%-8.8M-43.21%-16.66M0.08%-13.26M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More